UPDATE : Tuesday, October 23, 2018
상단여백
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Lee Han-soo  |  2018-07-17 14:52
라인
30% of psoriasis patients take more than 5 years to find correct therapy
Psoriasis patients see an average of three doctors and try four types of tr...
by Marian Chu  |  2018-07-17 14:52
라인
Pharmbio launched CINV treatment
Pharmbio Korea said Tuesday that it has released a prefilled syringe versio...
by Lee Han-soo  |  2018-07-17 14:02
라인
Korean eye drops selling well overseas
Korean eye drops made by Huons, Sam Chun Dang Pharm, and Hanlim Pharm are i...
by So Jae-hyeon  |  2018-07-17 11:36
라인
Multinational pharma focus on P3 trials; locals have more P1 trials
Multinational pharmaceutical firms had more phase 3 trials underway in Kore...
by Marian Chu  |  2018-07-17 11:27
라인
Access Bio signs $1.12-mil. contract for malaria diagnostic test
Access Bio is expanding its reach into Africa with its malaria rapid diagno...
by Marian Chu  |  2018-07-16 16:23
라인
FDA nods Qurient’s multidrug-resistant TB treatment for P2 clinical trials
Qurient said Monday that the U.S. Food and Drug Administration (FDA) has ap...
by Lee Han-soo  |  2018-07-16 15:10
라인
Korean take more drugs than OECD average
Koreans take more medications than most other members of the Organization f...
by Lee Han-soo  |  2018-07-16 12:37
라인
Japanese drugmakers in Korea showed robust performances last year
Japanese multinational pharmaceutical companies have continued to show robu...
by Lee Han-soo  |  2018-07-13 16:32
라인
Samsung BioLogics violated accounting standards: SFC
The Securities and Futures Commission (SFC) said Thursday it has concluded ...
by Lee Han-soo  |  2018-07-12 18:36
라인
Edarbi, Saxenda prescribed in major hospitals
A new hypertension drug Edarbi by Takeda Pharmaceuticals Korea and Dong-A S...
by So Jae-hyeon  |  2018-07-11 15:42
라인
‘Invossa-K will get US approval in 3 years, mark billion dollar sales’
Kolon Tissuegene is accelerating its advance into the U.S. to attain visibl...
by Lee Han-soo  |  2018-07-10 17:01
라인
Orders for original drugs spike amid ban of Chinese valsartan
With the government’s ban on the import and sale of generic drugs containin...
by Park Gi-taek  |  2018-07-10 16:03
라인
Shire launches new Hemophilia A treatment in Korea
Adynovate Shire Korea, the local branch of the global biotech pharmaceuti...
by Lee Han-soo  |  2018-07-10 13:51
라인
Ban of antihypertensive drug puts Korean drugmakers in panic
The government’s ban of 128 antihypertensive drugs using valsartan manufact...
by Lee Hye-seon/Nam Doo-hyun  |  2018-07-09 16:24
라인
Local drug makers strive to conquer neurological diseases
Korean pharmaceutical and biotech companies keep challenging to develop neu...
by So Jae-hyeon  |  2018-07-09 12:09
라인
Pharmbio to enter Mongol’s colonoscopy market
Pharmbio Korea announced its intention Monday to enter the Mongol’s colonos...
by Lee Han-soo  |  2018-07-09 11:20
라인
Tresiba vs. Toujeo competition heats up with head-to-head study results
Competition between two diabetes treatments -- Novo Nordisk’s Tresiba and S...
by Marian Chu  |  2018-07-06 16:40
라인
Ministry approves CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Friday that it has received sales approval for K-CAB, a ...
by Lee Han-soo  |  2018-07-06 14:56
라인
Generic copies of Avodart ready to hit market
Local pharmaceutical companies are preparing to release generic copies of A...
by Lee Hye-seon  |  2018-07-05 14:58
여백
여백
여백
Back to Top